FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Dawn Zhu

Research Profile

Chemicals & Drugs

Living Beings

Anatomy

Disorders

Co-author Network

Publications

TOP 3
Sonya G Lehto; Rami Tamir; Hong Deng; Lana Klionsky; Rongzhen Kuang; April Le; Doo Lee; Jean-Claude Louis; Ella Magal; Barton H Manning; John Rubino; Sekhar Surapaneni; Nuria Tamayo; Tingrong Wang; Judy Wang; Jue Wang; Weiya Wang; Brad Youngblood; Maosheng Zhang; Dawn Zhu; Mark H Norman; Narender R Gavva
Antihyperalgesic effects of (R,E)-N-(2-hydroxy-2,3-dihydro-1H-inden-4-yl)-3-(2-(piperidin-1-yl)-4-(trifluoromethyl)phenyl)-acrylamide (AMG8562), a novel transient receptor potential vanilloid type 1 modulator that does not cause hyperthermia in rats.
Narender R Gavva; Anthony W Bannon; David N Hovland; Sonya G Lehto; Lana Klionsky; Sekhar Surapaneni; David C Immke; Charles Henley; Leyla Arik; Annette Bak; James Davis; Nadia Ernst; Gal Hever; Rongzhen Kuang; Licheng Shi; Rami Tamir; Jue Wang; Weiya Wang; Gary Zajic; Dawn Zhu; Mark H Norman; Jean-Claude Louis; Ella Magal; James J S Treanor
Repeated administration of vanilloid receptor TRPV1 antagonists attenuates hyperthermia elicited by TRPV1 blockade.
Kenneth D Wild; Di Bian; Dawn Zhu; James Davis; Anthony W Bannon; Tie J Zhang; Jean-Claude Louis
Antibodies to nerve growth factor reverse established tactile allodynia in rodent models of neuropathic pain without tolerance.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Dawn Zhu (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2008: Sonya G Lehto; Rami Tamir; Hong Deng; Lana Klionsky; Rongzhen Kuang; April Le; Doo Lee; Jean-Claude Louis; Ella Magal; Barton H Manning; John Rubino; Sekhar Surapaneni; Nuria Tamayo; Tingrong Wang; Judy Wang; Jue Wang; Weiya Wang; Brad Youngblood; Maosheng Zhang; Dawn Zhu; Mark H Norman; Narender R Gavva
Antihyperalgesic effects of (R,E)-N-(2-hydroxy-2,3-dihydro-1H-inden-4-yl)-3-(2-(piperidin-1-yl)-4-(trifluoromethyl)phenyl)-acrylamide (AMG8562), a novel transient receptor potential vanilloid type 1 modulator that does not cause hyperthermia in rats.
The Journal of pharmacology and experimental therapeutics 2008;326(1):218-29.
2007: Narender R Gavva; Anthony W Bannon; David N Hovland; Sonya G Lehto; Lana Klionsky; Sekhar Surapaneni; David C Immke; Charles Henley; Leyla Arik; Annette Bak; James Davis; Nadia Ernst; Gal Hever; Rongzhen Kuang; Licheng Shi; Rami Tamir; Jue Wang; Weiya Wang; Gary Zajic; Dawn Zhu; Mark H Norman; Jean-Claude Louis; Ella Magal; James J S Treanor
Repeated administration of vanilloid receptor TRPV1 antagonists attenuates hyperthermia elicited by TRPV1 blockade.
The Journal of pharmacology and experimental therapeutics 2007;323(1):128-37.
2007: Kenneth D Wild; Di Bian; Dawn Zhu; James Davis; Anthony W Bannon; Tie J Zhang; Jean-Claude Louis
Antibodies to nerve growth factor reverse established tactile allodynia in rodent models of neuropathic pain without tolerance.
The Journal of pharmacology and experimental therapeutics 2007;322(1):282-7.
2007: Narender R Gavva; Anthony W Bannon; Sekhar Surapaneni; David N Hovland; Sonya G Lehto; Anu Gore; Todd Juan; Hong Deng; Bora Han; Lana Klionsky; Rongzhen Kuang; April Le; Rami Tamir; Jue Wang; Brad Youngblood; Dawn Zhu; Mark H Norman; Ella Magal; James J S Treanor; Jean-Claude Louis
The vanilloid receptor TRPV1 is tonically activated in vivo and involved in body temperature regulation.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2007;27(13):3366-74.
2006: Vassil I Ognyanov; Chenera Balan; Anthony W Bannon; Yunxin Bo; Celia Dominguez; Christopher Fotsch; Vijay K Gore; Lana Klionsky; Vu V Ma; Yi-Xin Qian; Rami Tamir; Xianghong Wang; Ning Xi; Shimin Xu; Dawn Zhu; Narender R Gavva; James J S Treanor; Mark H Norman
Design of potent, orally available antagonists of the transient receptor potential vanilloid 1. Structure-activity relationships of 2-piperazin-1-yl-1H-benzimidazoles.
Journal of medicinal chemistry 2006;49(12):3719-42.
2005: Narender R Gavva; Rami Tamir; Yusheng Qu; Lana Klionsky; Tie J Zhang; David C Immke; Judy Wang; Dawn Zhu; Todd W Vanderah; Frank Porreca; Elizabeth M Doherty; Mark H Norman; Kenneth D Wild; Anthony W Bannon; Jean-Claude Louis; James J S Treanor
AMG 9810 [(E)-3-(4-t-butylphenyl)-N-(2,3-dihydrobenzo[b][1,4] dioxin-6-yl)acrylamide], a novel vanilloid receptor 1 (TRPV1) antagonist with antihyperalgesic properties.
The Journal of pharmacology and experimental therapeutics 2005;313(1):474-84.